Drug Topics July 2019

PBMs are making it nearly impossible to navigate the waters of healthcare, writes Kreckle. 

Agents of regulatory guidance, drug problem reports, and whistleblowers.

FDA plans to finalize the draft in 2019. 

"Neither your gut nor peer advice will get you the caliber people you need", writes Nathan

First oral drug for advanced or metastatic bladder cancer.

New study examines effective implementation of team-based care in community pharmacies. 

Changes fueled by the 2003 Medicare Prescription Drug Improvement and Modernization Act.

Comprehensive medication management may lower costs and improve lives. 

Exciting and upcoming developments, years in the making.

By 2020, industry experts believe specialty drugs will account for 50% of U.S. spending on pharmaceuticals.

At the 2019 Asembia Specialty Pharmacy Summit, former FDA Commissioner Scott Gottlieb discussed advances within the agency during his tenure.

Value-based programs emphasize better care, enhanced health, and lower costs. 

3.5 million Americans estimated to be living with chronic HCV infection, but half may not know. 

Affordable dispensing robots are opening new opportunities for community pharmacies.

Type 2 diabetes mellitus is a risk factor for incident heart failure, according to a new scientific statement from the American Heart Association (AHA), and it increases the risk of morbidity and mortality in patients with established disease.

Organization calls for state-level legislative and regulatory revisions.

Results from a new Massachusetts Health Policy Commission report.

Pharmacists can earn up to 27 hours of CE. 

CVS will expand its health offerings, including nutrition and weight loss.

Results of a recent survey suggest employee-based drug abuse is a concern for many healthcare providers, though they don’t believe it can happen in their facilities.

Earn up to 19.25 hours of CE.